Composition for body fat reduction

A composition and fat technology, applied in the direction of drug combination, application, food science, etc., to achieve the effect of inhibiting the increase of body fat and reducing body fat

Inactive Publication Date: 2008-01-23
FUJI CHEM IND CO LTD
View PDF9 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] However, it has not been reported that astaxanthin and the extract obtained by pulverizing Haematococcus and extracting it with a solvent can reduce body fat and inhibit the increase of body fat, and as a result, have the effect of treating or preventing obesity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0077] In order to further describe the present invention in detail, the following examples are given, of course, the present invention is not limited to the examples.

[0078] [Preparation method of Haematococcus extract]

[0079] Disperse 80 kg of dry, uncrushed Haematococcus powder (manufactured by AstaReal AB, with an astaxanthin content of 3.7%) and 2 kg of multivitamin E (Riken Vitamin, E700) in 120 kg of acetone, using a glass ball filled with 85% of 1 mm diameter glass beads. Explosion-proof bead mill testing machine (Dainomil KDL-25BC, manufactured by WAB), while timely cooling, at room temperature, the disc peripheral speed is 10m / s, and the flow rate is 100kg / hour. Carotenoid-containing lipids are extracted at the same time. qualitative components. The total amount of the pulverized suspension is suction-filtered, the extraction filtrate is recovered, and the filter residue is rinsed three times with 40 kg of acetone to completely extract the lipid components conta...

manufacture example 1

[0093] [Manufacturing example 1] tablet

[0094] The following ingredients were mixed according to the following composition ratio (% by weight) by a uniform dry method to form a powder, and then prepared into tablets of 300 mg each.

[0095] Haematococcus Extract 30mg

[0096] Lactose 70mg

[0097] Starch 70mg

[0098] Sodium Caseinate 6mg

[0099] Gelatin 6mg

[0100] Fiber 109mg

[0101] Silica 3mg

[0102] Sucrose fatty acid esters 6mg

[0103] The Haematococcus extract contained 5% by weight in terms of free form of astaxanthin.

[0104] [Preparation 2] soft capsules

[0105] Haematococcus extract (containing 5% by weight astaxanthin) is mixed with edible oil, and filled into soft capsule shells containing the following ingredients according to conventional methods to obtain 300 mg soft capsules.

[0106] contents

[0107] Haematococcus Extract 20mg

[0108] Edible oil 150mg

[0109] agent shell

[0110] Gelatin 100mg

[0111] Glycerin 30mg

preparation example 3

[0112] [Preparation Example 3] Oral Liquid

[0113] Mix the following ingredients, add 10kg of water according to a conventional method, and prepare an oral liquid.

[0114] Haematococcus extract aqueous solution * 25g

[0115] Liquid sugar 4000g

[0116] DL-sodium tartrate 1g

[0117] Citric acid 50g

[0118] Vitamin C 50g

[0119] Vitamin E 150g

[0120] Cyclodextrin 25g

[0121] Potassium chloride 5g

[0122] Magnesium Sulfate 2g

[0123] * Haematococcus extract aqueous solution (containing 1% astaxanthin) prepared according to the method of embodiment in Japanese Patent Laid-Open 2001-316601

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An increase in body fat is one of main causes of life-style-related diseases such as hypertension, insulin tolerance, and hyperlipemia. A composition for body fat reduction is provided which inhibits body fat from decreasing or increasing and which is effective in the treatment and prevention of adult diseases a cause of which is body fat. Also provided are a medicine and a food each containing the composition. [MEANS FOR SOLVING PROBLEMS] The composition for body fat reduction comprises (A) astaxanthin and (B) at least one of an active ingredient, an adsorbent, and a solubilizer. Alternatively, it comprises (A) a Haematococcus pluvialis extract containing astaxanthin and (B) at least one of an active ingredient, an adsorbent, and a solubilizer.

Description

technical field [0001] The present invention relates to a composition for reducing body fat containing astaxanthin as an active ingredient, and a composition for reducing body fat obtained by pulverizing Haematococcus and extracting it with a solvent. By administering these compositions in the form of medicines or ingesting them as a diet, medicines and foods effective in the prevention, improvement and treatment of body fat loss or obesity or diseases associated therewith can be obtained. Background technique [0002] In recent years, due to the intake of high-calorie foods, changes in lifestyle, lack of exercise, stress, etc., lifestyle diseases have increased and become a major social problem. In particular, obesity or overweight caused by an increase in body fat rate has become a major problem accounting for more than 20% of the total population in Japan. Obesity refers to a physical condition in which the energy intake exceeds the energy expended, and adipose tissue ac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/122A61K36/02A61K45/08A61P3/04A61P39/06A23L1/30A23L1/307A23L33/20
CPCA61K36/05A23V2002/00A61K9/4858A61K45/06A61K9/1652A23L1/337A61K9/0095A23L1/2753A61K9/2054A61K31/122A23L1/3002A23L5/44A23L33/105A23L17/60A61P1/12A61P1/14A61P1/18A61P11/00A61P11/16A61P13/02A61P13/12A61P15/08A61P17/00A61P19/02A61P19/06A61P21/00A61P25/00A61P25/02A61P25/04A61P25/20A61P25/22A61P25/28A61P27/00A61P27/02A61P27/12A61P27/16A61P29/00A61P3/00A61P3/10A61P35/00A61P3/04A61P3/06A61P37/00A61P37/04A61P37/08A61P39/06A61P43/00A61P9/00A61P9/02A61P9/04A61P9/10A61P9/12A61P9/14A61K2300/00A23V2200/332A23V2250/202A23V2250/211
Inventor 高桥二郎山下荣次深间内诚田中公
Owner FUJI CHEM IND CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap